Viewing StudyNCT04760730



Ignite Creation Date: 2024-05-06 @ 3:48 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04760730
Status: COMPLETED
Last Update Posted: 2022-10-26
First Post: 2021-02-17

Brief Title: Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 COVID-19
Sponsor: R-Pharm
Organization: R-Pharm

Organization Data

Organization: R-Pharm
Class: INDUSTRY
Study ID: CV03872091
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: R-Pharm
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
AstraZeneca INDUSTRY